Navigation Links
Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System

Study Will Investigate Using Cooling Device to Treat Heart Attack Victims

WALDWICK, N.J., Oct. 20 /PRNewswire/ -- Life Recovery Systems has received a competitively awarded $700,000 grant from the National Institutes of Health (NIH) to conduct a clinical study to investigate the feasibility of cooling heart attack patients with its ThermoSuit(R) System, the only cooling device using cold water immersion to rapidly lower patient temperature.

The grant was awarded through the Small Business Innovation Research (SBIR) program of the National Heart, Lung and Blood Institute (NHLBI) of NIH. This is the third SBIR grant for Live Recovery Systems from NHLBI. The two previous grants totaling $1.3 million were to develop the ThermoSuit System.

Twenty patients will be enrolled in the study, which will be conducted under an Investigational Device Exemption that was previously granted to Life Recovery Systems by the Food and Drug Administration. The study is a cooperative effort between Life Recovery Systems and the Ochsner Clinic in New Orleans, a division of Ochsner Health System, a non-profit academic and healthcare delivery system with seven hospitals and more than 35 health centers in Southeast Louisiana.

The trial will explore the feasibility of cooling heart attack (ST-elevation acute myocardial infarction) patients with the ThermoSuit System before blood flow is restored to the heart. Patients will be sedated and cooled after entry into the emergency room and prior to percutaneous coronary intervention in the catheterization laboratory. It is expected that the ThermoSuit System will enable cooling of the patient to 34 degrees C after a treatment of 30 minutes or less and within the 90-minute door to balloon time requirement for treating ST-elevation acute myocardial infarction patients.

A successful result of the study will lead to a pivotal clinical study to investigate the potential for the ThermoSuit cooling treatment to reduce the severity of the heart attack. Previous research has suggested that cooling of some types of heart attack patients before coronary reperfusion could result in a significant reduction in the amount of injury the heart suffers.

The ultimate goal of these studies is to obtain FDA clearance for the use of the ThermoSuit System in treating heart attack patients. Life Recovery Systems believes that this would contribute to better outcomes for such patients and thus substantially increase the potential uses and market for its unique cooling technology.


Judd Cohen

Cohen Communications


SOURCE Life Recovery Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
2. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
5. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
6. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
7. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
8. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
9. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
10. StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection
11. PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S.
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
Breaking Medicine Technology:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... to the creativity of two inventors, one from Lakewood, New Jersey and the other ... They developed the patent-pending PROTECTOR to save the expense of having to replace NuvaRings ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... University of Toronto and the University of British Columbia suggested that laws requiring bicyclists ... The article explains that part of the reason for the controversial conclusion is that, ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):